Heart scan AI could predict sudden cardiac death risk in common heart condition
NCT ID NCT07695272
First seen Jul 10, 2026 ยท Last updated Jul 10, 2026
Summary
This study looks at whether detailed analysis of heart MRI images (called radiomics) can better predict life-threatening heart rhythms in people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens. Researchers will also see if the drug mavacamten, which helps relieve obstruction in some HCM patients, leads to changes in these imaging features that might lower risk over time. The goal is to improve current risk prediction tools, which are only moderately accurate.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- mavacamten
- What this could lead to
- If successful, this could lead to more accurate, personalized risk assessments for sudden cardiac death in people with hypertrophic cardiomyopathy, and show whether mavacamten treatment changes that risk over time.
- What could go wrong
- This is an observational and exploratory study, not a treatment trial. The radiomics approach is still being tested and may not improve prediction enough to change clinical practice. Results may take years to confirm.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC MYOSIN INHIBITORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Cardiologico Monzino; IRCCS
Milan, Milan, 20133, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental pill aims to ease thick heart muscle symptoms
- Massive HCM database aims to unlock better heart care
- Heart drug swap tested for safer symptom control
- Real-World HCM drug use under the microscope
- Heart drug mavacamten shows promise in Real-World study
- Can a new heart drug improve blood flow in thick heart muscle?